Annie Gardner

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Kim Papp, James G. Krueger, Steven R. Feldman et al. · Journal of the American Academy of Dermatology · 2016 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial

John S. Bradley, Emmanuel Roilides, Helen Broadhurst et al. · The Pediatric Infectious Disease Journal · 2019 · 71 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial

John S. Bradley, Helen Broadhurst, Karen Cheng et al. · The Pediatric Infectious Disease Journal · 2019 · 68 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +16

Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study

Fernando Valenzuela, Neil J. Korman, Robert Bissonnette et al. · British Journal of Dermatology · 2018 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

T-cell–mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment

Kevin Winthrop, Neil J. Korman, William Abramovits et al. · Journal of the American Academy of Dermatology · 2018 · 35 citations

Life Sciences, Dermatology, Immunology +17